Mast cells in autoantibody responses and arthritis

Novartis Foundation Symposium

Volumn 271, Issue , 2005, Pages 200-209

  Nigrovic, P A ^a,b   Lee, D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G;

ANIMAL; ARTHRITIS; DISEASE MODEL; HUMAN; IMMUNOLOGY; MAST CELL; MOUSE; NEUTROPHIL; PATHOLOGY; REVIEW; SYNOVIUM; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN G; MAST CELLS; MICE; MICE, TRANSGENIC; NEUTROPHILS; RECEPTORS, FC; SYNOVIAL MEMBRANE;

EID: 33745302873     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (62)

1. Abe M, Kurosawa M, Ishikawa O et al 2000 Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol 106:S78-S84
2. Applequist SE, Wallin RP, Ljunggren HG 2002 Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 14:1065-1074
3. Broder I, Urowitz MB, Gordon DA 1972 Appraisal of rheumatoid arthritis as an immune complex disease. Medical Clinics of North America 56:529-539
4. Bromley M, Woolley DE 1984 Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum 27:857-863
5. Bromley M, Fisher WD, Woolley DE 1984 Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis 43:76-79
6. Bryce PJ, Miller ML, Miyajima I et al 2004 Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20:381-392
7. Buckley MG, Walters C, Wong WM et al 1997 Mast cell activation in arthritis: detection of alpha-and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci (Lond) 93:363-370
8. Ceponis A, Konttinen YT, Takagi M et al 1998 Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation. J Rheumatol 25:2304-2314
9. Chen R, Ning G, Zhao ML et al 2001 Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 108:1151-1158
10. Corr M, Crain B 2002 The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis. J Immunol 169:6604-6609
11. Crisp AJ, Chapman CM, Kirkham SE et al 1984 Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 27:845-851
12. Diaz de Stahl T, Andren M, Martinsson P et al 2002 Expression of FcgammaRIII is required for development of collagen-induced arthritis. Eur J Immunol 32:2915-2922
13. Echtenacher B, Mannel DN, Hultner L 1996 Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75-77
14. Frewin DB, Cleland LG, Jonsson JR et al 1986 Histamine levels in human synovial fluid. J Rheumatol 13:13-14
15. Galli SJ, Tsai M, Wershil BK 1993 The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 142:965-974
16. Godfrey HP, Ilardi C, Engber W et al 1984 Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 27:852-856
17. Goodarzi K, Goodarzi M, Tager AM et al 2003 Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4:965-973
18. Gotis-Graham I, Smith MD, Parker A et al 1998 Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis 57:664-671
19. Gruber B, Poznansky M, Boss E et al 1986 Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum 29:944-955
20. Gruber BL, Kew RR, Jelaska A et al 1997 Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 158:2310-2317
21. Gryfe A, Sanders PM, Gardner DL 1971 The mast cell in early rat adjuvant arthritis. Ann Rheum Dis 30:24-30
22. Huttunen M, Naukkarinen A, Horsmanheimo M et al 2002 Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing. Arch Dermatol Res 294:324-330
23. Jawdat DM, Albert EJ, Rowden G et al 2004 IgE-Mediated Mast Cell Activation Induces Langerhans Cell Migration In Vivo. J Immunol 173:5275-5782
24. Ji H, Ohmura K, Mahmood U et al 2002 Arthritis critically dependent on innate immune system players. Immunity 16:157-168
25. Jones VE, Jacoby RK, Cowley PJ et al 1982 Immune complexes in early arthritis. II. Immune complex constituents are synthesized in the synovium before rheumatoid factors. Clin Exp Immunol 49:31-40
26. Jordana M, Befus AD, Newhouse MT et al 1988 Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 43:552-558
27. Kiener HP, Baghestanian M, Dominkus M et al 1998 Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. Arthritis Rheum 41:233-245
28. Kiener HP, Hofbauer R, Tohidast-Akrad M et al 2000 Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis. Arthritis Rheum 43:164-174
29. Kinsella TD, Baum J, Ziff M 1969 Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane. Clin Exp Immunol 4:265-271
30. Korganow AS, Ji H, Mangialaio S et al 1999 From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10:451-461
31. Kouskoff V, Korganow AS, Duchatelle V et al 1996 Organ-specific disease provoked by systemic autoimmunity. Cell 87:811-822
32. Lavery JP, Lisse JR 1994 Preliminary study of the tryptase levels in the synovial fluid of patients with inflammatory arthritis. Ann Allergy 72:425-427
33. Lee DM, Friend DS, Gurish MF et al 2002 Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297:1689-1692
34. Li CY, Baek JY 2002 Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol 127:123-126
35. Liu Z, Giudice GJ, Swartz SJ et al 1995 The role of complement in experimental bullous pemphigoid. J Clin Invest 95:1539-1544
36. Maccioni M, Zeder-Lutz G, Huang H et al 2002 Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 195:1071-1077
37. Malaviya R, Ikeda T, Ross E et al 1996a Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77-80
38. Malaviya R, Twesten NJ, Ross EA et al 1996b Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156:1490-1496
39. Malaviya R, Gao Z, Thankavel K et al 1999 The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 96:8110-8115
40. Malone DG, Irani AM, Schwartz LB et al 1986 Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 29:956-963
41. Malone DG, Wilder RL, Saavedra-Delgado AM et al 1987 Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum 30:130-137
42. Matsumoto I, Staub A, Benoist C et al 1999 Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286:1732-1735
43. Matsumoto I, Maccioni M, Lee DM et al 2002 How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 3:360-365
44. McCurdy JD, Olynych TJ, Maher LH et al 2003 Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170:1625-1629
45. Metcalfe DD, Baram D, Mekori YA 1997 Mast cells. Physiol Rev 77:1033-1079
46. Nigrovic PA, Lee DM 2005 Mast cells in inflammatory arthritis Arthritis Res Ther 7:1-11
47. Nilsson G, Johnell M, Hammer CH et al 1996 C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157:1693-1698
48. Okayama Y, Kirshenbaum AS, Metcalfe DD 2000 Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol 164:4332-4339
49. Partsch G, Schwagerl W, Eberl R 1982 Histamine in rheumatic diseases (German). Z Rheumatol 41:19-22
50. Pekin TJ, Jr., Zvaifler NJ 1964 Hemolytic Complement in Synovial Fluid. J Clin Invest 43:1372-1382
51. Ramos BF, Zhang Y, Jakschik BA 1994 Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J Immunol 152:1380-1384
52. Rodman WS, Williams RC, Jr., Bilka PJ et al 1967 Immunofluorescent localization of the third and the fourth component of complement in synovial tissue from patients with rheumatoid arthritis. J Lab Clin Med 69:141-150
53. Ruddy S, Britton MC, Schur PH et al 1969 Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis. Ann NY Acad Sci 168:161-172
54. Sellge G, Lorentz A, Gebhardt T et al 2004 Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J Immunol 172:260-267
55. Tager AM, Bromley SK, Medoff BD et al 2003 Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4:982-990
56. Tetlow LC, Woolley DE 1995 Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 54:549-555
57. van den Broek MF, van den Berg WB, van de Putte LB 1988 The role of mast cells in antigen induced arthritis in mice. J Rheumatol 15:544-551
58. Wang Y, Kristan J, Hao L et al 2000 A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 164:4340-4347
59. Watson WC, Brown PS, Pitcock JA et al 1987 Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum 30:460-465
60. Winchester RJ, Agnello V, Kunkel HG 1969 An association between the gG complexes and complement depletion in joint fluids of patients with rheumatoid arthritis. Arthritis & Rheumatism 12:343
61. Zhang Y, Ramos BF, Jakschik BA 1991 Augmentation of reverse arthus reaction by mast cells in mice. J Clin Invest 88:841-846
62. Zhang Y, Ramos BF, Jakschik BA 1992 Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258:1957-1959